NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
NIKA PHARMACEUTICALS, INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.41+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $431.19M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0689 (−14.39%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $431.19M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$78.14K
- EPS, diluted
- $0.00
- Book value per share
- -$0.00
- Diluted shares
- 1.05B
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$78.14K
Net income
-$78.14K
EPS, diluted
$0.00
Reported periodTrailing twelve months